Drawing based on the label description. No photo yet.
“2.5 mg tablets: yellow round, biconvex, film coated tablets imprinted with 'LT' on one side and plain on other side”
LT pill
Pill with imprint LT is yellow, round, 6 mm and has been identified as Letrozole 2.5 mg. It is used for breast cancer. It is supplied by Nucare Pharmaceuticals,inc.
Letrozole 2.5 mg
- Imprint
- LT
- Strength
- 2.5 mg
- Used for
- Breast cancer
- Color
- Yellow
- Shape
- Round
- Size
- 6 mm
- Score
- No score line
- Form
- Tablet, film coated
- Manufacturer
- Nucare Pharmaceuticals,inc
- Drug class
- Breast cancer medicine (aromatase inhibitor)
- NDC
- 68071-2167, 16729-034, 68071-2167-4, 68071-5264, 68071-5264-3, 17856-0032, 17856-0032-1, 16729-034-10, 16729-034-15, 16729-034-01, 16729-034-16, 16729-034-17, 16729-034-43, 63629-7819, 63629-7819-1, 63629-7819-2, 63629-7819-3, 63629-7819-4, 50090-3474, 50090-3474-0
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Letrozole used for?
Letrozole is used for breast cancer.
- Medicine type
- Breast cancer medicine (aromatase inhibitor)
Official uses from the US prescribing label
Adjuvant Treatment of Early Breast Cancer
Letrozole tablets are indicated for the adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.
Extended Adjuvant Treatment of Early Breast Cancer
Letrozole tablets are indicated for the extended adjuvant treatment of early breast cancer in postmenopausal women, who have received 5 years of adjuvant tamoxifen therapy. The effectiveness of letrozole tablets in extended adjuvant treatment of early breast cancer is based on an analysis of disease-free survival (DFS) in patients treated with letrozole tablets for a median of 60 months.
First and Second-Line Treatment of Advanced Breast Cancer
Letrozole tablets are indicated for first-line treatment of postmenopausal women with hormone receptor positive or unknown, locally advanced or metastatic breast cancer. Letrozole tablets are also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy.
From the FDA-approved label on DailyMed (published Aug 21, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- One side shows LT and the other side is plain.
- It is yellow, round, 6 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Ingredients
Active: Letrozole
Inactive: Silicon Dioxide, Hypromellose 2910 (6 Mpa.s), Ferric Oxide Yellow, Lactose Monohydrate, Magnesium Stearate, Starch, Corn, Cellulose, Microcrystalline, Polyethylene Glycol 400, Sodium Starch Glycolate Type A Potato, Talc, Titanium Dioxide
Also distributed by
Atlantic Biologicals Corp., Accord Healthcare, Inc., Bryant Ranch Prepack, A-S Medication Solutions
Other pills with imprint LT
Same imprint, different listing. Check the color, size and maker against your pill.
- LT Abacavir and Lamivudine 600 mg / 300 mg Orange, capsule, 21 mm Used for HIV
- LT Letrozole 2.5 mg Yellow, round Used for breast cancer
- LT Letrozole 2.5 mg Yellow, round Used for breast cancer
- LT Letrozole 2.5 mg Yellow, round Used for breast cancer
- LT Letrozole 2.5 mg Yellow, round Used for breast cancer
- LT Letrozole 2.5 mg Yellow, round Used for breast cancer
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
AN 247
Chlorthalidone 25 mg
Yellow, round, 6 mm
Used for high blood pressure and heart failure
-
J 5
Prochlorperazine Maleate 5 mg
Yellow, round, 7 mm
Used for anxiety and schizophrenia
-
AN899 15
Aripiprazole 15 mg
Yellow, round, 6 mm
Used for schizophrenia
-
C
Olmesartan Medoxomil 5 mg
Yellow, round, 5 mm
Used for high blood pressure and heart failure
-
497
Zolmitriptan 2.5 mg
Yellow, round, 7 mm
Used for migraine
-
G 51
Solifenacin Succinate 5 mg
Yellow, round, 6 mm
Used for overactive bladder
Other Letrozole pills
- M L71 Letrozole 2.5 mg Pink, round, 6 mm Used for breast cancer
- FV CG Letrozole 2.5 mg Yellow, round, 7 mm Used for breast cancer
- TEVA B1 Letrozole 2.5 mg Yellow, round, 6 mm Used for breast cancer
- WW 74 Letrozole 2.5 mg Yellow, round, 6 mm Used for breast cancer
- LET 2 5 Letrozole 2.5 mg Yellow, round, 6 mm Used for breast cancer
- N L Letrozole 2.5 mg Yellow, round, 6 mm Used for breast cancer
- L2 5 Letrozole 2.5 mg Yellow, round, 6 mm Used for breast cancer
- 121 YL Letrozole 2.5 mg Yellow, round, 6 mm Used for breast cancer